Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ganzina

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Haematologica|January 1, 1989
Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemiaG Leone, L Pagano, R Marra, et al.
Tumori|February 28, 1987
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomasG Abate, P Comella, N Di Pietro, et al.
Cancer Investigation|January 1, 1988
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC)A Ardizzoni, P Pronzato, L Repetto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
European Journal of Cancer & Clinical Oncology|July 1, 1987
Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemiaG Lambertenghi-Deliliers, A T Maiolo, C Annaloro, et al.
Haematologica|January 1, 1989
Idarubicin combined with intermediate-dose cytosine arabinoside in the treatment of refractory acute leukemiaG Leone, L Pagano, R Marra, et al.
Tumori|February 28, 1987
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomasG Abate, P Comella, N Di Pietro, et al.
Cancer Investigation|January 1, 1988
Phase II trial of oral idarubicin in advanced non-small cell lung cancer (NSCLC)A Ardizzoni, P Pronzato, L Repetto, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1982
Pharmacokinetic approach to the selection of dose schedules for medroxyprogesterone acetate in clinical oncologyV Tamassia, A Battaglia, F Ganzina, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.
Pageof 3